After years of structural deficits that drove palladium to all-time highs above $3,400/oz in 2022, the market's fundamental balance has undergone a decisive reversal. Johnson Matthey's 2026 PGM Report projects a modest surplus of 214,000 oz for palladium this year, while Heraeus sees a widening surplus that underpins its bearish $950-1,500/oz price range. (FACT: Johnson Matthey, 2026; Heraeus, May 2026) The shift reflects two structural megatrends: the irreversible platinum-for-palladium substitution in autocatalysts, and the long-term erosion of gasoline-vehicle demand as the global fleet electrifies.
The substitution story is the most powerful force. During the years when palladium traded at a significant premium to platinum — at times exceeding $2,000/oz more — automakers and catalyst manufacturers invested heavily in reformulating catalytic converters to use platinum instead of palladium. By the World Platinum Investment Council's estimates, approximately 700,000 oz of annual palladium demand was displaced by platinum substitution in 2024 alone. (FACT: WPIC, 2026) Critically, the WPIC has stated that this substitution is "unlikely to reverse swiftly" due to platform lock-in. Once a catalyst formulation is validated, tested, and integrated into a vehicle platform — a process that takes roughly seven years from design to production — reversing the substitution requires a similarly lengthy re-engineering cycle. Even though palladium is now cheaper than platinum on a relative basis (spot Pd at ~$1,700 vs. Pt at ~$1,976), automakers cannot simply switch back overnight.
The automotive demand outlook compounds the challenge. Palladium derives 80-85% of its total demand from gasoline autocatalysts, making it uniquely exposed to the structural decline of internal combustion engines. While the pace of BEV adoption has moderated in some markets — the US EV tax credit rollback and strong hybrid sales have extended the ICE timeline — the direction of travel is clear. Each year, a larger share of new vehicle production is either fully electric (zero palladium) or hybrid (reduced palladium loading versus conventional ICE). Metals Focus projects palladium to underperform platinum and rhodium in 2026, with price appreciation of just +37% versus +71% for platinum. (FACT: Metals Focus, ValueTheMarkets, May 19, 2026)
Despite this bearish structural backdrop, the palladium market is not pricing in a collapse to the $950 floor that Heraeus identifies as the bottom of its range. Spot metal holding near $1,700/oz as of late May reflects the powerful countervailing force of concentrated supply risk. Russia (approximately 40% of global primary supply) and South Africa (approximately 30-40%) together dominate the palladium production landscape. The US anti-dumping action against Russian material, combined with ongoing operational risks at South African mines — power shortages, labour disputes, and declining ore grades — means that a small supply disruption could quickly erase a notional surplus. (FACT: Heraeus, Reuters, JPMorgan, 2026) Johnson Matthey itself notes that a 214,000 oz surplus is "modest relative to the historical scale of the palladium market" and remains "exposed to reversal" from production disruptions or an unexpected recovery in gasoline vehicle output.
JPMorgan's mine supply forecast of -3% in 2026 further underscores the fragility of the supposed surplus. Nornickel is ramping Chernogorskoye toward 6.2 Moz, but geopolitical trade frictions increasingly divert those Russian ounces away from the Western markets that set global benchmark prices. The net effect is a market caught between two opposing forces: a structurally deteriorating demand outlook that argues for lower prices, and a supply base so concentrated that any disruption could trigger a violent short-covering rally. (FACT: JPMorgan, Reuters, 2026)
The surplus narrative is real but fragile. For procurement teams with multi-year planning horizons, the structural case for lower palladium prices is compelling — but timing the market is treacherous. The surplus is small relative to historical standards and easily disrupted. The optimal strategy may be barbelled: secure long-term supply agreements that reflect the bearish fundamentals (perhaps index-linked with floor provisions), while maintaining tactical inventory buffers to hedge against the supply-risk tail. The Heraeus forecast suggests that patient buyers could see $1,200-1,400/oz levels later in 2026 if surplus builds and no supply shocks materialize. But the Russia/SA supply concentration means that any procurement plan assuming a $1,000/oz world should include robust contingency for a swift return to $2,000+.